Innovative Product Offering Bloomer Tech has developed the world's first medical-grade wearable garment that combines everyday apparel with advanced digital biomarkers for women's cardiovascular health, presenting a unique opportunity to target health providers, women’s health clinics, and wearable tech markets seeking personalized diagnostics.

Strong Research Funding With recent investments from NIH and private investors totaling over 6 million dollars, Bloomer Tech demonstrates robust backing for clinical trials and product validation, making it an appealing partner for hospitals, research institutions, and insurance providers interested in evidence-based cardiovascular solutions for women.

Market Focus on Women's Health Specialized in addressing sex and ethnicity-specific cardiovascular conditions through digital biomarkers, the company offers a compelling value proposition for healthcare providers, women’s health organizations, and targeted therapeutics companies aiming to improve health outcomes in underserved populations.

Early Stage Growth Operating with a small but growing team and revenue between 1 to 10 million dollars, Bloomer Tech presents a scalable opportunity for distribution partners, clinical networks, and device integrators seeking innovative, personalized monitoring solutions as the market for women's cardiovascular health expands.

Technology and Data Capabilities Leveraging over 30 years of research and proprietary textile-based sensors, Bloomer Tech can generate unique datasets and digital biomarkers, creating opportunities for collaborations with data analytics firms, pharmaceutical companies, and medical device integrators interested in advancing personalized medicine and diagnostics.